Dr. Sater is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3502 SE Burk Ct
Fort Pierce, FL 34984
Summary
- Dr. Sater is a physician entrepreneur, a visionary healthcare leader, and an innovative scientist disrupting current healthcare delivery in oncology to help cancer patients fight with dignity, live longer, and enjoy a good quality of life. This stems from his core belief that we treat humans and not cases. As a pathologist and translational researcher Dr. Sater founded and led the Tumor Immune MicroEnvironment (TIME) Laboratory at the NCI (2017-2021) which continues to serve many laboratories and clinical trials at the NIH. The TIME lab is a lifelong investment with many publications to come and serve the scientific community. Dr Sater is also a clinical trialist (Hematologist Oncologist running clinical trials) and a research leader translating epigenetic and immune biomarker discovery knowledge into innovative immune-oncology trials. Dr Sater moved to the state of sunshine bringing his 20+ experience to the community where he envisioned delivering high-quality care to patients. He served the Treasure Coast by raising millions of philanthropy and grant dollars which helped build a research team and bring in over 20 innovative clinical trials, which will continue to serve the community. In his current endeavor, Dr. Sater started a very promising company "HAS Consulting" which will change the way cancer therapy is delivered to patients. This is a global platform with very high standards connecting the top experts in their field with patients across the globe and uses the most innovative tools to care for our loved ones including artificial intelligence, centralized drug delivery, and other adaptive concepts personalized to patients' needs.
Twitter: https://twitter.com/HSaterMD
Education & Training
- Medical College of GeorgiaChief Residency, Hematology and Medical Oncology, 2016 - 2017
- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2011 - 2014
- Lebanese University School of MedicineClass of 2007
Certifications & Licensure
- IL State Medical License 2024 - 2026
- CO State Medical License 2024 - 2025
- FL State Medical License 2021 - 2025
- IN State Medical License 2024 - 2025
- WI State Medical License 2024 - 2025
- WV State Medical License 2024 - 2025
- MD State Medical License 2017 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers Start of enrollment: 2021 Oct 05
- Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer Start of enrollment: 2022 Apr 14
- Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer Start of enrollment: 2021 Apr 21
Publications & Presentations
PubMed
- 43 citationsNascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.Scott Wilkinson, Huihui Ye, Fatima Karzai, Stephanie Harmon, Nicholas T. Terrigino
European Urology. 2021-03-27 - 34 citationsA Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced CancerMargaret E. Gatti-Mays, Jason M. Redman, Renee N. Donahue, Claudia Palena, Ravi A. Madan
The Oncologist. 2020-06-01 - 18 citationsA Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.Jason M Redman, Yo-Ting Tsai, Benjamin A Weinberg, Renee N Donahue, Shruti Gandhy
The Oncologist. 2022-03-11
Press Mentions
- Top Doctor 2023December 4th, 2023
- Dr SaterApril 7th, 2022
- Updates on Immunotherapy for Lung Cancer PatientsApril 7th, 2022
- Join now to see all
Committees
- Chair, Protocol Review Committee, Cleveland Clinic 2022 - Present
Research History
- Regional Research Director, Cancer Institute, Cleveland Clinic Florida2022 - Present
- Clinical Research Director, Cleveland Clinic Martin Health2021 - Present
- Head, Tumor MicroEnvironment Labortory, National Cancer Institute2017 - 2021
Professional Memberships
- Member
- Society for Immunotherapy of Cancer (SITC)Member
Other Languages
- Arabic, French, Russian
External Links
- Top Doctorhttps://www.castleconnolly.com/top-doctors/houssein-abdul-sater-medical-oncology-cc92413
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: